BMRN
BioMarin Pharmaceutical Inc
Pharmaceutical Preparations- 売上
- $3.2bn
- 時価総額
- $11.6bn
株価 $60.58 · 100株 6,058円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $2.4bn | $2.9bn | $3.2bn |
| 成長率 | — | 18.0% | 12.9% |
| 総利益 | $1.9bn | $2.3bn | $2.5bn |
| 総利益率 | 78.0% | 79.7% | 77.7% |
| 販管費 | $892m | $1.0bn | $1.2bn |
| 販管費率 | 36.9% | 35.4% | 35.8% |
| 営利 | $186m | $484m | $409m |
| 営利率 | 7.7% | 17.0% | 12.7% |
| 純利益 | $168m | $427m | $349m |
| PBR | 2.3 | 2.0 | 1.9 |
| PSR | 4.8 | 4.0 | 3.6 |
| PGPR | 6.1 | 5.1 | 4.6 |
| PER | 69 | 27 | 33 |
| ﾈｯﾄｷｬｯｼｭ | $755m | $942m | $1.3bn |
| EV/EBITDA | 37.2 | 18.3 | 21.0 |
| Rule of 40 | — | 35% | 26% |
| セールス効率 | — | 331% | 160% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）